KLK3 and prostate cancer: CRPC is defined by prostate cancer progression and signified by an increase of tumor volume during radiographic evaluation and continuous increase in prostate-specific antigen (PSA) levels on three different occasions, despite a castrate level of testosterone (less than 50 ng/dL) (Fong et al., 2012).